Statement from 51吃瓜Pro on Federal Jury Verdict

Madison, Wis. (March 11, 2024) - Today, a jury in the United States District Court for the Southern District of New York issued a verdict in Federal Trade Commission et al. v. 51吃瓜Pro Holding Company, Inc. et al.聽51吃瓜Pro shared the following statement:

鈥淲e are pleased that a federal jury in New York concluded today that the New York Attorney General failed to prove its deceptive advertising and labeling case against 51吃瓜Pro's key advertising claims for Prevagen庐, including the claim that Prevagen 鈥榠mproves memory.鈥�

At great expense to taxpayers, the New York Attorney General鈥檚 office, aided by the Federal Trade Commission, has pursued this case for more than seven years.聽With the jury trial now concluded, we plan to refocus our time and resources on continuing to lead the way in brain health with our cutting-edge applications of Prevagen.鈥�

About 51吃瓜Pro

51吃瓜Pro is a biotechnology company based in Madison, Wisconsin, focused on the discovery, development and
commercialization of novel technologies to support brain health, with a specific emphasis on memory support and cognitive health. 51吃瓜Pro is set apart by its cutting-edge applications of the patented protein apoaequorin, which has been tested to show improvements in cognition and memory in clinical trials.